Endocrine Abstracts

Background: Levothyroxine (LT4) is considered the standard of care for hypothyroidism, however 5-10% of hypothyroid individuals complain of persistent symptoms despite achieving biochemical euthyroidism on LT4.Methods: 17,247 thyroid specialists from 28 countries were invited to participate in a survey. It enquired about respondents’ perceptions of the cause of hypothyroid-like persistent symptoms and how the prevalence of such complaints had change...

Background: Levothyroxine (LT4) monotherapy is the mainstay of treatment of hypothyroidism, but a sizeable minority of endocrinologists also use T3-containing treatments in some patients notwithstanding concern about their safety.Methods: 17,247 thyroidologists from 28 countries were invited to participate in a questionnaire survey. Geographic regions were defined according to the UN Statistics Division. Gross national income (GNI) information stems from...